Metformin Medical Valley (Metformin Hydrochloride)

Metformin reduces hepatic glucose production by inhibiting mitochondrial complex I and activates AMP‑activated protein kinase (AMPK). This dual action decreases gluconeogenesis, improves peripheral insulin sensitivity, and modestly reduces intestinal glucose absorption, resulting in lower circulating glucose levels.

The dose of Metformin Medical Valley is individualized by the prescribing clinician based on the patient’s renal function, glycemic targets, and tolerability. The prescriber determines the appropriate starting dose and any subsequent titration, following local prescribing guidelines.

Metformin crosses the placenta and is excreted in breast milk. It may be used during pregnancy or lactation only when the potential benefit outweighs the risk, and after careful evaluation by the treating physician. Women should discuss any concerns with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metformin is a first‑line biguanide that improves insulin sensitivity without causing hypoglycemia, unlike sulfonylureas which stimulate insulin release. Compared with newer agents such as SGLT2 inhibitors or GLP‑1 receptor agonists, metformin is generally less expensive and has a well‑established safety profile, though combination therapy may be needed for optimal control.

Store Metformin Medical Valley at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Metformin Medical Valley is taken orally, usually with meals to reduce gastrointestinal discomfort. The tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse event is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or excessive alcohol intake. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or unexplained fatigue develop.

Metformin is contraindicated in individuals with known hypersensitivity to metformin, severe renal impairment (eGFR <30 mL/min/1.73 m²), acute or chronic metabolic acidosis, and in patients receiving iodinated contrast agents for imaging studies unless renal function is re‑evaluated afterward.